Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma

Journal of Clinical Oncology

Volumn 26, Issue 4, 2008, Pages 657-664

  Tse, Regina V ^a   Hawkins, Maria ^a   Lockwood, Gina ^a   Kim, John J ^a   Cummings, Bernard ^a   Knox, Jennifer ^a   Sherman, Morris ^a   Dawson, Laura A ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER ENZYME;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER TOXICITY; LIVER WEIGHT; MALE; PRIORITY JOURNAL; RADIATION DOSE; STEREOTACTIC BODY RADIOTHERAPY TREATMENT; STEREOTACTIC TREATMENT; TUMOR VOLUME; CLINICAL TRIAL; GASTROINTESTINAL HEMORRHAGE; INTESTINE OBSTRUCTION; LIVER TUMOR; MIDDLE AGED; MORTALITY; PHASE 1 CLINICAL TRIAL; RADIATION INJURY; RADIOSURGERY; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; INTESTINAL OBSTRUCTION; LIVER NEOPLASMS; MALE; MIDDLE AGED; RADIATION INJURIES; RADIOSURGERY; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 39149134352     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.14.3529     Document Type: Article

References (34)

1. Parkin DM, Bray F, Ferlay J, et al: Global cancer statistics, 2002. CA Cancer J Clin 55:74-108, 2005
2. El-Serag HB, Mason AC: Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340:745-750, 1999
3. Chou FF, Sheen-Chen SM, Chen YS, et al: Surgical treatment of cholangiocarcinoma. Hepato-Gastroenterology 44:760-765, 1997
4. Kuvshinoff BW, Ota DM: Radiofrequency ablation of liver tumors: Influence of technique and tumor size. Surgery 132:605-611, 2002
5. Solbiati L, Livraghi T, Goldberg SN, et al: Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: Long-term results in 117 patients. Radiology 221:159-166, 2001
6. Cammà C, Schepis F, Orlando A, et al: Transarterial chemoembolization for unresectable hepatocellular carcinoma: Meta-analysis of randomized controlled trials. Radiology 224:47-54, 2002
7. Yeo W, Mok TS, Zee B, et al: A randomized phase III study of doxorubicin versus cisplatin/ interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma. J Natl Cancer Inst 97:1532-1538, 2005
8. Leung TW, Patt YZ, Lau WY, et al: Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma. Clin Cancer Res 5:1676-1681, 1999
9. Knox JJ, Hedley D, Oza A, et al: Combining gemcitabine and capecitabine in patients with advanced biliary cancer: A phase II trial. J Clin Oncol 23:2332-2338, 2005
10. Abou-Alfa GK, Schwartz L, Ricci S, et al: Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. J Clin Oncol 24:4293-4300, 2006
11. Philip PA, Mahoney MR, Allmer C, et al: Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer. J Clin Oncol 23:6657-6663, 2005
12. Philip PA, Mahoney MR, Allmer C, et al: Phase II study of erlotinib in patients with advanced biliary cancer. J Clin Oncol 24:3069-3074, 2006
13. Lawrence TS, Robertson JM, Anscher MS, et al: Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 31:1237-1248, 1995
14. Eccles C, Brock KK, Bissonnette JP, et al: Reproducibility of liver position using active breathing coordinator for liver cancer radiotherapy. Int J Radiat Oncol Biol Phys 64:751-759, 2006
15. Ten Haken RK, Martel MK, Kessler ML, et al: Use of Veff and iso-NTCP in the implementation of dose escalation protocols. Int J Radiat Oncol Biol Phys 27:689-695, 1993
16. Méndez Romero A, Wunderink W, Hussain SM, et al: Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase I-II study. Acta Oncol 45:831-837, 2006
17. Wulf J, Guckenberger M, Haedinger U, et al: Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol 45:838-847, 2006
18. Dawson LA, Eccles C, Craig T: Individualized image guided iso-NTCP based liver cancer SBRT. Acta Oncol 45:856-864, 2006
19. Rietzel E, Pan T, Chen GT: Four-dimensional computed tomography: Image formation and clinical protocol. Med Phys 32:874-889, 2005
20. Dawson LA, Eccles C, Bissonnette JP, et al: Accuracy of daily image guidance for hypofractionated liver radiotherapy with active breathing control. Int J Radiat Oncol Biol Phys 62:1247-1252, 2005
21. Hawkins MA, Brock KK, Eccles C, et al: Assessment of residual error in liver position using kV cone-beam computed tomography for liver cancer high-precision radiation therapy. Int J Radiat Oncol Biol Phys 66:610-619, 2006
22. Mornex F, Girard N, Beziat C, et al: Feasibility and efficacy of high-dose three-dimensional radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies: Mature results of the French phase II RTF-1 trial. Int J Radiat Oncol Biol Phys 66:1152-1158, 2006
23. Liu MT, Li SH, Chu TC, et al: Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization. Jpn J Clin Oncol 34:532-539, 2004
24. Seong J, Park HC, Han KH, et al: Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: A retrospective study of 158 patients. Int J Radiat Oncol Biol Phys 55:329-336, 2003
25. Park HC, Seong J, Han KH, et al: Doseresponse relationship in local radiotherapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 54:150-155, 2002
26. Park W, Lim DH, Paik SW, et al: Local radiotherapy for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 61:1143-1150, 2005
27. Ben-Josef E, Normolle D, Ensminger WD, et al: Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol 23:8739-8747, 2005
28. McGinn CJ, Ten Haken RK, Ensminger WD, et al: Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model. J Clin Oncol 16:2246-2252, 1998
29. Dawson LA, McGinn CJ, Normolle D, et al: Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 18:2210-2218, 2000
30. Chiba T, Tokuuye K, Matsuzaki Y, et al: Proton beam therapy for hepatocellular carcinoma: A retrospective review of 162 patients. Clin Cancer Res 11:3799-3805, 2005
31. Blomgren H, Lax I, Goranson H, et al: Radiosurgery for tumors in the body: Clinical experience using a new method. J Radiosurg 1:63-74, 1998
32. Herfarth KK, Debus J, Lohr F, et al: Stereotactic single-dose radiation therapy of liver tumors: Results of a phase I/II trial. J Clin Oncol 19:164-170, 2001
33. Schöniger-Hekele M, Hanel S, Wrba F, et al: Hepatocellular carcinoma-survival and clinical characteristics in relation to various histologic molecular markers in Western patients. Liver Int 25:62-69, 2005
34. Fujii T, Takayasu K, Muramatsu Y, et al: Hepatocellular carcinoma with portal tumor thrombus: Analysis of factors determining prognosis. Jpn J Clin Oncol 23:105-109, 1993